drugset / Trial / NCT00136110
Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether the use of sodium valproate is effective in slowing the disease progression in Amyotrophic Lateral Sclerosis.
Timeline
- Start
- 2005-04
- Primary completion
- —
- Completion
- 2007-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Valproate | Small molecule | 1500 mg | — |